{"id":"https://openalex.org/W4409529285","doi":"https://doi.org/10.1016/j.ijpharm.2025.125581","title":"Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim","display_name":"Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim","publication_year":2025,"publication_date":"2025-04-17","ids":{"openalex":"https://openalex.org/W4409529285","doi":"https://doi.org/10.1016/j.ijpharm.2025.125581","pmid":"https://pubmed.ncbi.nlm.nih.gov/40252867"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2025.125581","doi":"https://doi.org/10.1016/j.ijpharm.2025.125581","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2025.125581","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ijpharm.2025.125581","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106811862","display_name":"Maxime Stoops","orcid":"https://orcid.org/0009-0008-2203-2157","observed_orcids":["https://orcid.org/0009-0008-2203-2157"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Maxime Stoops","raw_affiliation_strings":["Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address: mstoops@chu-grenoble.fr"],"raw_orcid":"https://orcid.org/0009-0008-2203-2157","affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address: mstoops@chu-grenoble.fr","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028589644","display_name":"Bernard Do","orcid":"https://orcid.org/0000-0002-1131-2080","observed_orcids":["https://orcid.org/0000-0002-1131-2080"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4210121618","display_name":"Institut des Sciences Mol\u00e9culaires d'Orsay","ror":"https://ror.org/0211r2z47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I4210121618"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bernard Do","raw_affiliation_strings":["Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Universit\u00e9 Paris-Saclay, CNRS, Institut des Sciences Mol\u00e9culaires d'Orsay, 91405 Orsay, France"],"raw_orcid":"https://orcid.org/0000-0002-1131-2080","affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Universit\u00e9 Paris-Saclay, CNRS, Institut des Sciences Mol\u00e9culaires d'Orsay, 91405 Orsay, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4210121618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000298753","display_name":"St\u00e9phanie Ramos","orcid":"https://orcid.org/0009-0003-8967-8001","observed_orcids":["https://orcid.org/0009-0003-8967-8001"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Ramos","raw_affiliation_strings":["Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bing Xun Tan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Xun Tan","raw_affiliation_strings":["Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, #05-06 Helios 138667, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, #05-06 Helios 138667, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117187727","display_name":"Nicholas Yong Sheng Chua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas Yong Sheng Chua","raw_affiliation_strings":["Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, #05-06 Helios 138667, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, #05-06 Helios 138667, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087730719","display_name":"Roseline Mazet","orcid":"https://orcid.org/0000-0002-1841-6691","observed_orcids":["https://orcid.org/0000-0002-1841-6691"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Roseline Mazet","raw_affiliation_strings":["CHU Grenoble Alpes, Department of Pharmacy, University Grenoble Alpes, 38700 Grenoble, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Grenoble Alpes, Department of Pharmacy, University Grenoble Alpes, 38700 Grenoble, France","institution_ids":["https://openalex.org/I2800555055","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042648803","display_name":"Nicolas Guiblin","orcid":"https://orcid.org/0000-0002-4418-0547","observed_orcids":["https://orcid.org/0000-0002-4418-0547"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210107720","display_name":"CentraleSup\u00e9lec","ror":"https://ror.org/019tcpt25","country_code":"FR","type":"facility","lineage":["https://openalex.org/I277688954","https://openalex.org/I4210107720"]},{"id":"https://openalex.org/I4387155244","display_name":"Laboratoire Structures, Propri\u00e9t\u00e9s et Mod\u00e9lisation des Solides","ror":"https://ror.org/01t05f005","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I4210107720","https://openalex.org/I4387155244"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Guiblin","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, CNRS, Laboratoire SPMS, 91190 Gif-sur-Yvette, France"],"raw_orcid":"https://orcid.org/0000-0002-4418-0547","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, CNRS, Laboratoire SPMS, 91190 Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I4210107720","https://openalex.org/I4387155244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025126961","display_name":"Alexandre Michelet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre Michelet","raw_affiliation_strings":["Applications Development Lab France, PerkinElmer, Les Algorithmes - B\u00e2timent Esope, route de l'Orme des Merisiers, 91190 Saint-Aubin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applications Development Lab France, PerkinElmer, Les Algorithmes - B\u00e2timent Esope, route de l'Orme des Merisiers, 91190 Saint-Aubin, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen Flynn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177879584","display_name":"Roquette Fr\u00e8res (France)","ror":"https://ror.org/00bywv891","country_code":"FR","type":"company","lineage":["https://openalex.org/I177879584"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephen Flynn","raw_affiliation_strings":["Roquette Fr\u00e8res, 101 Av. de la R\u00e9publique, 59110 La Madeleine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roquette Fr\u00e8res, 101 Av. de la R\u00e9publique, 59110 La Madeleine, France","institution_ids":["https://openalex.org/I177879584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081263181","display_name":"Samuel D. Abbou","orcid":"https://orcid.org/0000-0002-7159-8869","observed_orcids":["https://orcid.org/0000-0002-7159-8869"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405255793","display_name":"Immunologie anti-tumorale et immunoth\u00e9rapie des cancers","ror":"https://ror.org/03e75qp68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4405255793"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Samuel Abbou","raw_affiliation_strings":["Children and Adolescent Oncology Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Universit\u00e9 Paris-Saclay, Institut Gustave Roussy, Inserm, Immunologie anti-tumorale et immunoth\u00e9rapie des cancers, 94805 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children and Adolescent Oncology Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Universit\u00e9 Paris-Saclay, Institut Gustave Roussy, Inserm, Immunologie anti-tumorale et immunoth\u00e9rapie des cancers, 94805 Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4405255793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031888549","display_name":"\u00c1lvaro Goyanes","orcid":"https://orcid.org/0000-0002-3378-6797","observed_orcids":["https://orcid.org/0000-0002-3378-6797"]},"institutions":[{"id":"https://openalex.org/I200284239","display_name":"Universidade de Santiago de Compostela","ror":"https://ror.org/030eybx10","country_code":"ES","type":"education","lineage":["https://openalex.org/I200284239"]},{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["ES","GB"],"is_corresponding":false,"raw_author_name":"Alvaro Goyanes","raw_affiliation_strings":["Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela 15782 Santiago de Compostela, Spain; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK"],"raw_orcid":"https://orcid.org/0000-0002-3378-6797","affiliations":[{"raw_affiliation_string":"Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela 15782 Santiago de Compostela, Spain; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK","institution_ids":["https://openalex.org/I200284239","https://openalex.org/I4210148771","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024089310","display_name":"Andr\u00e9 Rieutord","orcid":"https://orcid.org/0000-0001-5935-7635","observed_orcids":["https://orcid.org/0000-0001-5935-7635"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Rieutord","raw_affiliation_strings":["Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054267552","display_name":"Fran\u00e7ois\u2010Xavier Legrand","orcid":"https://orcid.org/0000-0002-7271-7284","observed_orcids":["https://orcid.org/0000-0002-7271-7284"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210117966","display_name":"Institut Galien Paris-Saclay","ror":"https://ror.org/02mnw9q71","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I4210117966","https://openalex.org/I4210128300"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois-Xavier Legrand","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France"],"raw_orcid":"https://orcid.org/0000-0002-7271-7284","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I277688954","https://openalex.org/I4210117966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056855451","display_name":"Maxime Annereau","orcid":"https://orcid.org/0000-0001-9594-2516","observed_orcids":["https://orcid.org/0000-0001-9594-2516"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Maxime Annereau","raw_affiliation_strings":["Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address: maxime.annereau@gustaveroussy.fr"],"raw_orcid":"https://orcid.org/0000-0001-9594-2516","affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address: maxime.annereau@gustaveroussy.fr","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5056855451","https://openalex.org/A5106811862"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":8.053,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.98143639,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"676","issue":null,"first_page":"125581","last_page":"125581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10783","display_name":"Additive Manufacturing and 3D Printing Technologies","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2209","display_name":"Industrial and Manufacturing Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10783","display_name":"Additive Manufacturing and 3D Printing Technologies","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2209","display_name":"Industrial and Manufacturing Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.028200000524520874,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12190","display_name":"Innovations in Concrete and Construction Materials","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2215","display_name":"Building and Construction"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/3d-printed-medicines","display_name":"3D-printed medicines","score":0.9259999990463257},{"id":"https://openalex.org/keywords/sulfamethoxazole","display_name":"sulfamethoxazole","score":0.8029999732971191},{"id":"https://openalex.org/keywords/trimethoprim","display_name":"trimethoprim","score":1.0},{"id":"https://openalex.org/keywords/pediatric-drug-formulation","display_name":"pediatric formulations","score":0.6050000190734863},{"id":"https://openalex.org/keywords/semi-solid-extrusion","display_name":"semi-solid extrusion","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chewable-tablets","display_name":"chewable tablets","score":0.9919999837875366},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8510000109672546},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.7770000100135803},{"id":"https://openalex.org/keywords/palatability","display_name":"palatability","score":0.7889999747276306},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.7590000033378601},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hospital-implementation","display_name":"hospital implementation","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C2779425571","wikidata":"https://www.wikidata.org/wiki/Q415843","display_name":"Sulfamethoxazole","level":3,"score":0.8140144348144531},{"id":"https://openalex.org/C2780728791","wikidata":"https://www.wikidata.org/wiki/Q422665","display_name":"Trimethoprim","level":3,"score":0.7765620350837708},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4752331078052521},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3219609260559082},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2721112370491028},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.22207510471343994},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07873710989952087}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066330","descriptor_name":"Printing, Three-Dimensional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ijpharm.2025.125581","doi":"https://doi.org/10.1016/j.ijpharm.2025.125581","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2025.125581","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:40252867","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40252867","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05038883v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05038883","pdf_url":"https://hal.science/hal-05038883v1/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics, 2025, 676, pp.125581. ⟨10.1016/j.ijpharm.2025.125581⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10208551","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10208551/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics , 676 , Article 125581. (2025)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.ijpharm.2025.125581","doi":"https://doi.org/10.1016/j.ijpharm.2025.125581","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2025.125581","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4879366418","display_name":"Roquette Freres","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409529285.pdf","grobid_xml":"https://content.openalex.org/works/W4409529285.grobid-xml"},"referenced_works_count":82,"referenced_works":["https://openalex.org/W1479971735","https://openalex.org/W1485271732","https://openalex.org/W1568537411","https://openalex.org/W1590784435","https://openalex.org/W1734011921","https://openalex.org/W1900493176","https://openalex.org/W1970409722","https://openalex.org/W1978018138","https://openalex.org/W1987955043","https://openalex.org/W2017274641","https://openalex.org/W2047375737","https://openalex.org/W2053551068","https://openalex.org/W2085475561","https://openalex.org/W2098761029","https://openalex.org/W2112722416","https://openalex.org/W2120000151","https://openalex.org/W2131734103","https://openalex.org/W2141378806","https://openalex.org/W2190308071","https://openalex.org/W2293902824","https://openalex.org/W2413613495","https://openalex.org/W2469864138","https://openalex.org/W2477597183","https://openalex.org/W2511976576","https://openalex.org/W2529451590","https://openalex.org/W2564139061","https://openalex.org/W2735898890","https://openalex.org/W2746474357","https://openalex.org/W2755463998","https://openalex.org/W2795803199","https://openalex.org/W2804154151","https://openalex.org/W2889356903","https://openalex.org/W2890285928","https://openalex.org/W2916770640","https://openalex.org/W2944869972","https://openalex.org/W2947698554","https://openalex.org/W2948898465","https://openalex.org/W2993848978","https://openalex.org/W3003558240","https://openalex.org/W3119284335","https://openalex.org/W3121920290","https://openalex.org/W3125912157","https://openalex.org/W3135396554","https://openalex.org/W3140444531","https://openalex.org/W3143645754","https://openalex.org/W3164864185","https://openalex.org/W3173376366","https://openalex.org/W3176305953","https://openalex.org/W3198288432","https://openalex.org/W3204044690","https://openalex.org/W4205677429","https://openalex.org/W4210293014","https://openalex.org/W4213097810","https://openalex.org/W4220953100","https://openalex.org/W4229378060","https://openalex.org/W4284675931","https://openalex.org/W4284976089","https://openalex.org/W4296181433","https://openalex.org/W4304165594","https://openalex.org/W4304688216","https://openalex.org/W4304757894","https://openalex.org/W4306964673","https://openalex.org/W4318205368","https://openalex.org/W4321375531","https://openalex.org/W4378213333","https://openalex.org/W4380356123","https://openalex.org/W4383105608","https://openalex.org/W4385065842","https://openalex.org/W4385462219","https://openalex.org/W4386570264","https://openalex.org/W4386701553","https://openalex.org/W4386782934","https://openalex.org/W4386858229","https://openalex.org/W4387159344","https://openalex.org/W4388342085","https://openalex.org/W4389159755","https://openalex.org/W4390196758","https://openalex.org/W4392918978","https://openalex.org/W4393282639","https://openalex.org/W4396937037","https://openalex.org/W4402009829","https://openalex.org/W4402521163"],"related_works":["https://openalex.org/W4213208542","https://openalex.org/W4410031168","https://openalex.org/W7158545165","https://openalex.org/W7127338109","https://openalex.org/W2774056644","https://openalex.org/W4224239764","https://openalex.org/W7130642204","https://openalex.org/W4283014412","https://openalex.org/W7155186372","https://openalex.org/W4402862013"],"abstract_inverted_index":{"Adherence":[0],"to":[1,34,37,68,114,133,142],"treatment":[2],"is":[3,48],"one":[4],"of":[5,56,60,72,116],"the":[6,19,43,54,108,117,128],"major":[7],"challenges":[8],"in":[9,25,46,82,148],"chronic":[10],"diseases.":[11],"Inappropriate":[12],"dosage":[13],"forms":[14],"or":[15],"bad":[16],"taste":[17],"are":[18,139],"main":[20],"factor":[21],"for":[22,64,78,96,145],"non-adherence,":[23],"especially":[24],"paediatric":[26,79,146],"patients.":[27],"3D":[28],"printed":[29],"medicines":[30,39],"could":[31],"be":[32],"tailored":[33],"specific":[35],"patients":[36,81,147],"make":[38],"more":[40,97],"acceptable,":[41],"however":[42],"clinical":[44],"implementation":[45],"hospitals":[47],"still":[49],"limited.":[50],"This":[51],"study":[52],"addresses":[53],"challenge":[55],"developing":[57],"pharma-inks":[58,89],"(mixtures":[59],"drugs":[61],"and":[62,75,87,92,107,153],"excipients)":[63],"semi-solid":[65],"extrusion":[66],"(SSE)":[67],"produce":[69],"chewable":[70,102],"tablets":[71,103],"Sulfamethoxazole":[73],"(SMX)":[74],"Trimethoprim":[76],"(TMP)":[77],"oncology":[80],"a":[83],"hospital":[84,149],"setting.":[85],"SMX":[86],"TMP":[88],"were":[90,104,112],"stable":[91],"printable":[93],"on":[94],"demand":[95],"than":[98],"3":[99],"months.":[100],"The":[101],"also":[105],"stable,":[106],"drug":[109],"dissolution":[110],"profiles":[111],"comparable":[113],"those":[115],"commercial":[118],"formulations,":[119],"indicating":[120],"potential":[121],"bioequivalence.":[122],"Human":[123],"sensory":[124],"evaluations":[125],"confirmed":[126],"that":[127],"formulation":[129],"improved":[130],"palatability":[131],"compared":[132],"traditional":[134,143],"suspensions.":[135],"3D-printed":[136],"SMX/TMP":[137],"formulations":[138,144],"an":[140],"alternative":[141],"settings,":[150],"enhancing":[151],"acceptability":[152],"adherence":[154],"while":[155],"enabling":[156],"personalized":[157],"dosing.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":8}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-04-17T00:00:00"}